Showing results (1401-1410 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|June 21, 2020
The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in miceStefania Cuzzubbo, Claire Banissi, Marie Sophie Rouchon, et al.Cancer Immunology, Immunotherapy : CII|October 20, 2019
Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantationJulia K Bialek-Waldmann, Michael Heuser, Arnold Ganser, et al.Cancer Immunology, Immunotherapy : CII|October 23, 2019
Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune responseVered Domankevich, Adi Cohen, Margalit Efrati, et al.Cancer Immunology, Immunotherapy : CII|April 20, 2020
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patientsYu Qi, Yu Xia, Zhiyuan Lin, et al.Cancer Immunology, Immunotherapy : CII|April 24, 2020
Advances and perspectives of dendritic cell-based active immunotherapies in follicular lymphomaMaria Christina Cox, Caterina Lapenta, Stefano M SantiniCancer Immunology, Immunotherapy : CII|September 13, 2025
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world studyCheoklong Ng, Taile Jing, Shicheng Yu, et al.Cancer Immunology, Immunotherapy : CII|August 14, 2025
Exploring IgSF11 as a potential immune checkpoint and immunotherapeutic target in breast cancerIbtissam Rezouki, Basma Zohair, Hamza Benthami, et al.Cancer Immunology, Immunotherapy : CII|September 10, 2025
Real-world treatment practices and survival outcomes of patients with de novo metastatic nasopharyngeal carcinoma after chemoimmunotherapyQin Lin, Yuan Zhou, Lin-Feng Guo, et al.Cancer Immunology, Immunotherapy : CII|August 4, 2025
GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosisMarta Kłopotowska, Iwona Baranowska, Szymon Hajduk, et al.Cancer Immunology, Immunotherapy : CII|September 29, 2025
Dynamic remodeling of tertiary lymphoid structures in response to cancer therapy: a recent reviewChongyu Tan, Jinliang Huang, Ning Gao, et al.Pageof 651